by Larussa, T. et al.
Department of Health Science, University of Catanzaro "Magna Graecia", Catanzaro, Italy
Department of Health Science, University of Catanzaro "Magna Graecia", Catanzaro, Italy
Six out of 27 (22%) current or past users of azathioprine developed ADR, with three (50%) displaying TPMT genotype and/or phenotype alterations.
Eur. J. Intern. Med. 2012; 3:273-7